469 studies found for:    "tetrasomy 18p" OR "Chromosomal Disorder"
Show Display Options
Rank Status Study
21 Completed Melatonin Levels in Smith Magenis Syndrome (SMS)
Condition: Chromosome Disorders
Interventions: Dietary Supplement: Melatonin;   Device: Enviro-light artificial light box
22 Terminated Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Conditions: Acute Myeloid Leukemia (AML);   Acute Promyelocytic Leukemia (APL);   Refractory Anemia With Excess of Blasts (RAEB)
Intervention:
23 Unknown  Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test
Condition: Post-natal Cytogenetics
Intervention:
24 Completed Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities
Conditions: Myelodysplastic Syndromes;   Leukemia, Myeloid, Acute
Intervention: Drug: 5 azacytidine
25 Completed
Has Results
Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
Condition: Myelodysplastic Syndromes
Intervention: Drug: lenalidomide
26 Completed
Has Results
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy;   Behavioral: Behavior Therapy
27 Completed
Has Results
Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality
Condition: Myelodysplastic Syndromes
Interventions: Drug: Lenalidomide 5 mg;   Drug: Lenalidomide 10 mg;   Drug: Placebo
28 Recruiting X-chromosome Inactivation, Epigenetics and the Transcriptome
Conditions: Turner Syndrome;   Klinefelter Syndrome;   Triple X Syndrome;   47 XYY Syndrome;   Aortic Aneurysm
Intervention:
29 Not yet recruiting RA-2 13-cis Retinoic Acid (Isotretinoin)
Conditions: Male Infertility;   Klinefelter's Syndrome;   Y-chromosome Microdeletions
Intervention: Drug: 13-cis retinoic acid
30 Completed Evaluation of Patients With Unresolved Chromosome Abnormalities
Conditions: Abnormalities;   Failure to Thrive;   Mental Retardation;   Microcephaly
Intervention:
31 Suspended Relationship of Genetic Differences to the Development of Chromosome Abnormalities
Condition: Radiation Exposure
Intervention:
32 Recruiting Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment
Condition: Phelan-McDermid Syndrome
Intervention:
33 Recruiting Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
Conditions: 22q13 Deletion Syndrome;   Phelan-McDermid Syndrome
Interventions: Drug: Insulin-Like Growth Factor-1 (IGF-1);   Drug: Normal saline
34 Recruiting Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome
Conditions: Klinefelter Syndrome;   XXY Syndrome
Interventions: Drug: Testosterone gel 1%;   Drug: Placebo gel
35 Completed Non-Invasive Screening for Fetal Aneuploidy
Conditions: Down Syndrome;   Edwards Syndrome
Intervention: Other: Maternal blood screening test for fetal aneuploidy
36 Recruiting Non-Invasive Chromosomal Evaluation of Trisomy Study
Conditions: Fetal Aneuploidy;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Down Syndrome
Intervention:
37 Completed Comparison of Aneuploidy Risk Evaluations
Conditions: Pregnancy;   Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Turners Syndrome
Intervention:
38 Completed Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Conditions: Down Syndrome (Trisomy 21);   Edwards Syndrome (Trisomy 18);   Patau Syndrome (Trisomy 13);   Turner Syndrome
Intervention:
39 Unknown  Metal Ions in Ceramic on Metal Total Hip Arthroplasty
Conditions: Osteoarthritis;   Avascular Necrosis;   Rheumatoid Arthritis;   Developmental Dysplasia of the Hip
Intervention:
40 Terminated Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes;   Acute Myelogenous Leukemia
Interventions: Drug: Azacitidine;   Drug: Lenalidomide

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years